Clinical Trial Update: A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice

View source ↗

Summary

A retrospective analysis from UK NHS practice assessing liver resection rates in metastatic colorectal cancer patients treated with chemotherapy plus cetuximab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED